Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Tigason improved hair growth in a boy with monilethrix without side effects.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Ruxolitinib can cause a delayed skin reaction on the nose.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Some drugs used to treat immune conditions may cause different types of hair loss.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

Baricitinib improved hair loss and arthritis in a lupus patient.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.